Global Analysis of Disposable E-cigarette Market

Aug.23.2022
Global Analysis of Disposable E-cigarette Market
A comprehensive report on the global disposable e-cigarette market, covering technology, competition, trends, and regional sales and growth rates.

The disposable e-cigarette market provides a first impression of the disposable e-cigarette industry, covering various product definitions, classifications, and participants in the industry chain structure. It offers quantitative and qualitative analyses for the global disposable e-cigarette market, taking into account the competitive landscape, development trends, and key success factors (CSFs) in the disposable e-cigarette industry. This comprehensive report is useful for business owners, customers, shareholders, manufacturers, suppliers, and distributors. The report emphasizes driving factors, limiting factors, opportunities, challenges, and trends.


This report is divided into several key regions from a geographical perspective. It covers the period from 2014 to 2027 and includes the sales, revenue, market share, and growth rate of e-cigarettes in 1. North America (including the United States, Canada, and Mexico), 2. Europe (including Germany, the United Kingdom, France, Italy, Russia, Turkey, among others), 3. Asia-Pacific (including China, Japan, South Korea, India, Australia, Indonesia, Thailand, the Philippines, Malaysia, and Vietnam), 4. South America (including Brazil, Argentina, Colombia, and others), and 5. the Middle East and Africa (including Saudi Arabia, the United Arab Emirates, Egypt, Nigeria, and South Africa).


This electronic cigarette market research/analysis report includes answers to the following questions: 1. What manufacturing technology is used for disposable e-cigarettes? What developments are currently taking place in this technology and what trends are these events leading to?


Who are the global key players in the disposable e-cigarette market? What are their company profiles, product information, and contact details?


What is the global market status of disposable e-cigarettes? What is the capacity, production value, cost, and profit of the disposable e-cigarette market?


What is the current state of the single-use e-cigarette industry market? What is the competition in the market, how are the companies performing, including Smart Pioneers? What is the market analysis for the single-use e-cigarette market in terms of applications and types?


What is the global forecast for the disposable electronic cigarette industry in terms of production capacity, output, and value? What is the assessment of costs and profits? What is the market share, supply, and consumption situation? How is the import and export situation?


What is the one-time electronic cigarette market chain analysis of upstream raw materials and downstream industries?


What is the economic impact of disposable e-cigarette industry? What are the global results of environmental macroeconomic analysis? What are the global trends in macroeconomic environmental development?


What is the current state of the disposable vaping market? What challenges and opportunities are present?


What are the key elements that should be considered when assessing the economic impact of the disposable e-cigarette industry and developing marketing strategies to respond to it?


A new study has been released that covers the current market size and growth rate of the disposable electronic cigarette industry for the past 5 years. The study outlines the key players/manufacturers, including Altria Group, MOJOUS, Imperial Brands, British American Tobacco, Japan Tobacco, International Vapor Group, Shenzhen Kang Er Technology, Philip Morris International, NicQuid, and Shenzhen IVPS Technology.


A further research report has been released concerning the current status and future trends of the global disposable electronic cigarette market. Additionally, the report segments the market in terms of type and application, allowing for a comprehensive and insightful analysis of the market overview and prospects.


Statement


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The translation of this article is only meant for communication and research within the industry.


Due to limitations in the compiler's ability, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


When it comes to any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS maintains full alignment with the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs data showed that illegal cigarettes and vape products seized during the first seven months of 2026 were valued at about PHP11.68 billion, exceeding the PHP2.516 billion recorded for the full year of 2025. The figures were disclosed by a Bureau of Customs official during a House Committee on Ways and Means hearing on tobacco excise tax reforms. Vape-related seizures were valued at about PHP1.65 billion, with most cases recorded at the Manila International Container Port. Customs officials said enforcement against illicit tobacco trade would continue.
Aug.26
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10